← Eichor
Study identifier: NCT06995911 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Virtual Far-sight Reading Device for Myopia Intervention Among Pre-myopic Children

Condition: Myopia · Pre-myopia  ·  Sponsor: Shanghai Eye Disease Prevention and Treatment Center

PhaseNA
Planned participants80
Who can joinAll sexes, 6 Years to 12 Years
Healthy volunteersNo

About this study

This clinical trial wants to find out if the Virtual Far-sight Reading Device can help prevent or slow down myopia progression in children and teenagers with pre-myopia. We also want to know what makes this treatment work better for some participants and check for any eye or body-related side effects over time. Main questions: Can using the Virtual Far-sight Reading Device reduce the risk of myopia? Is the device safe to use every day for up to 6 months? What we'll do: Researchers will compare two groups of children: Group A: Uses the device for reading/writing (at least 1 hour daily) Group B: Does regular reading/writing without the device After 90 days, the groups will switch to see if the results stay the same. Participants will: * Have free eye checkups 3 times over 6 months * Use the device during homework time (if in the desk group) * Report any eye discomfort or problems

This description comes directly from the study's public registry record.

Talk to the study team

Wei Xu, Prof  ·  +86 18521513008  ·  vvxuwei@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Shanghai Eye Disease Prevention and Treatment CenterShanghai, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06995911